AusPAR: Sarilumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Sarilumab (rch) [PDF, 5.12 MB]

AusPAR: Sarilumab (rch) [Word, 13.13 MB]

Attachment: Product Information: Sarilumab (rch) [PDF, 388.61 KB]

Attachment: Product Information: Sarilumab (rch) [Word, 377.92 KB]

Device/Product Name

Kevzara

Active ingredients

Sarilumab (rch)

AusPAR Date

8 April 2019

Published

24 June 2019

Submission Number

PM-2017-03119-1-3

Submission Type

Extension of indications

Decision

Approved